Patents Assigned to Polymedix, Inc.
  • Patent number: 7553876
    Abstract: Aspects of the present invention relate to compounds and methods useful in modulating angiogenesis and methods of treating or preventing diseases associated with angiogenesis by administering a polycationic compound. The present invention relates to methods of use and compositions for inhibiting angiogenesis-mediated disorders in mammals including animals and humans. Additionally, this invention relates to the combined use of polycations with other anti-angiogenesis agents for the treatment of different angiogenesis-mediated disorders. Additionally, those polycationic compounds can be used with various anti-inflammatory and cytotoxic agents as well as with radio-therapeutic agents in cancer patients to prevent and treat tumor growth and metastasis.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: June 30, 2009
    Assignee: Polymedix, Inc.
    Inventor: Mousa Shaker
  • Publication number: 20090081153
    Abstract: The present invention provides compositions comprising a synthetic antimicrobial polymer and/or oligomer and a sesquiterpenoid compound useful in reducing the growth of microbes.
    Type: Application
    Filed: August 14, 2008
    Publication date: March 26, 2009
    Applicant: POLYMEDIX, INC.
    Inventors: Richard W. Scott, Byron F. Brehm-Stecher